Bioo Scientific MaxDiscovery AST and LDH colour endpoint assay kits

Thursday, 07 October, 2010 | Supplied by: GeneWorks

Bioo Scientific’s MaxDiscovery Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) colour endpoint assays use a proprietary technology for visible detection of in vivo toxicity using only 5 µL of serum from rodents or other mammals. These assays are powerful tools for the detection of drug-induced toxicity to the liver and heart and can be used for preclinical testing in the drug discovery process.

The assays employ simplified endpoint analysis to offer high sensitivity, low detection limits and the ability to use a visible plate reader.

The MaxDiscovery Aspartate Transaminase (AST) kit permits quantitative visible determination of AST in a convenient format. Unlike previous LDH tests, the MaxDiscovery LDH Color Endpoint Assay kit measures the direct chemical conversion of LDH and does not rely on coupled enzymatic amplification for high-precision, quantitative measurements. Each kit contains ready-to-use product standards for the development of standard curves and accurate calibration of the assay.

Phone: 08 8159 6250
Related Products

Illumina Nextera Flex for Enrichment sequencing solution

The Illumina Nextera Flex for Enrichment is a targeted sequencing solution.

Blackrock CerePlex Exilis wireless digital head stage for small animals

CerePlex Exilis from Blackrock Microsystems is a lightweight, wireless digital head stage that...

Phenosys rodent virtual reality systems

Virtual reality systems by Phenosys enable rats and mice to enter a virtual reality world. The...

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd